Drugmaker Granules India’s step-down subsidiary Granules Consumer Health Inc. (GCH) has accomplished an audit by the U.S. Food and Drug Administration (U.S. FDA) with zero observations.
The audit, of the agency’s packaging web site in Manassas, was a pre-approval inspection for 3 merchandise filed from the power. It was inspected from March 15-20. “The packaging site strengthens our proposition to control the value chain and provides us with the agility needed in a very dynamic OTC space,” stated Priyanka Chigurupati, Executive- Director, Granules USA Inc and Granules Pharmaceuticals, Inc.
GCH is a private-label OTC supplier and its packaging facility will allow it to service main retailers extra successfully. The packaging facility in Manassas, Virginia, is unfold over 79,000 sq ft and has a number of packaging suites to service buyer wants. The firm stated GCH was established in 2014 to supply OTC generics, the corporate stated.
On Tuesday, Granules India shares closed 2.29% greater at ₹288.30 apiece on BSE.
